These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7433476)

  • 1. A double-blind, multi-centre controlled trial of 0.25% oxymetazoline ophthalmic solution in patients with allergic and non-infectious conjunctivitis.
    Breakey AS; Cinotti AA; Hirshman M; Skowron RA; Samson CR; Danzig MR
    Pharmatherapeutica; 1980; 2(6):353-6. PubMed ID: 7433476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of topical oxymetazoline in treating allergic and environmental conjunctivitis.
    Duzman E; Warman A; Warman R
    Ann Ophthalmol; 1986 Jan; 18(1):28-31. PubMed ID: 3513687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxymetazoline ophthalmic solution versus naphazoline solution in non-infectious conjunctivitis.
    Rybiczka R; Mauracher E
    Pharmatherapeutica; 1983; 3(6):376-81. PubMed ID: 6353428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxymetazoline in the treatment of allergic and non-infectious conjunctivitis.
    Fox SL; Samson CR; Danzig MR
    J Int Med Res; 1979; 7(6):528-30. PubMed ID: 391626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of oxymetazoline and naphazoline in benign red eyes: a double blind comparative clinical trial.
    Nayak BK; Kishore K; Gupta SK
    Indian J Ophthalmol; 1987; 35(4):190-3. PubMed ID: 3333648
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sodium cromoglycate eyewash in allergic conjunctivitis. Multicentric controlled double-blind study. Review of the literature].
    Bec P; Berard P; Bonnet M; Cazillas JM; Chagnon A; Ducourneau D; Fallas MC; Farnarier G; François P; Jourdan-Fonta D; Kastler M; Langle D; Mouillac-Gambarelli N; Morris D; Ourgaud AG; Pouliquen Y
    J Fr Ophtalmol; 1982; 5(11):727-32. PubMed ID: 6818269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antazoline phosphate and naphazoline hydrochloride, singly and in combination for the treatment of allergic conjunctivitis-a controlled, double-blind clinical trial.
    Miller J; Wolf EH
    Ann Allergy; 1975 Aug; 35(2):81-6. PubMed ID: 1096685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind clinical trial wtih cromoglycate eye drops in patients with atopic conjunctivitis.
    Simon-Licht IF; Dieges PH
    Ann Allergy; 1982 Oct; 49(4):220-4. PubMed ID: 6812469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of ragweed allergic conjunctivitis with 2% cromolyn solution in unit doses.
    Nizami RM
    Ann Allergy; 1981 Jul; 47(1):5-7. PubMed ID: 6789720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical sodium cromoglycate in management of chronic non-infectious conjunctivitis: a double blind controlled clinical trial.
    Vajpayee RB; Gupta SK; Angra SK
    Indian J Ophthalmol; 1985; 33(5):285-8. PubMed ID: 3939626
    [No Abstract]   [Full Text] [Related]  

  • 11. Nedocromil sodium 2% ophthalmic solution for the treatment of ragweed pollen seasonal allergic conjunctivitis.
    Blumenthal MN; Schwartz RH; Kaiser H
    Ocul Immunol Inflamm; 2000 Sep; 8(3):159-67. PubMed ID: 11120577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
    Mah FS; Rosenwasser LJ; Townsend WD; Greiner JV; Bensch G
    Curr Med Res Opin; 2007 Jun; 23(6):1445-52. PubMed ID: 17559743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
    Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
    Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent allergic conjunctivitis: an assessment of 2% sodium cromoglycate eye drops. A multicentre general practitioner study.
    Practitioner; 1979 Jun; 222(1332):854-6. PubMed ID: 113783
    [No Abstract]   [Full Text] [Related]  

  • 15. Clobetasone treatment of allergic conjunctivitis: a comparative double blind study.
    Cerqueti PM; Prosio PE; Bosia S; Buscaglia S; Ciprandi G
    Allergol Immunopathol (Madr); 1993; 21(2):67-70. PubMed ID: 8337991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and toleration of oxymetazoline ophthalmic solution.
    Samson CR; Danzig MR; Sasovetz D; Thompson HS
    Pharmatherapeutica; 1980; 2(6):347-52. PubMed ID: 7433475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-masked comparison of ocular decongestants as therapy for allergic conjunctivitis.
    Lanier BQ; Tremblay N; Smith JP; deFaller JM
    Ann Allergy; 1983 Mar; 50(3):174-7. PubMed ID: 6338768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of the effect of oxymetazoline on the duration of rhinitis. results of a placebo-controlled double-blind study in patients with acute rhinitis].
    Reinecke S; Tschaikin M
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():113-8. PubMed ID: 16261947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic staphylococcal blepharoconjunctivitis with a new topical steroid anti-infective ophthalmic solution.
    Donshik P; Kulvin SM; Mckinley P; Skowron R
    Ann Ophthalmol; 1983 Feb; 15(2):162-7. PubMed ID: 6340583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.